Vaccination trial with HPV16 L1E7 chimer
✍
Andreas M. Kaufmann; John D. Nieland; Ingrid Jochmus; Siegfried Baur; Klaus Frie
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
French
⚖ 173 KB
## Abstract Persistent infection with human papillomaviruses (HPV) is a prerequisite for the development of cervical cancer. Vaccination with virus‐like particles (VLP) has demonstrated efficacy in prophylaxis but lacks therapeutic potential. HPV16 L1E7 chimeric virus‐like particles (CVLP) consist